Introduction
This article reviews important milestones in the evolution of the biochemical analysis of cerebrospinal fluid (CSF). Historically, knowledge of the biochemistry of CSF lagged far behind that of blood and urine, mainly because the fluid was much less readily accessible. However, by the time procurement of CSF by lumbar puncture became established as a routine clinical procedure, chemical methods for assaying a large number of analytes in blood had already been adequately established. Many of these methods were later adapted to CSF analysis and this, no doubt, facilitated more rapid development of the subject. Examination of CSF was, indeed, the first ancillary investigation to be introduced into the practice of clinical neurology and, for a considerable time, stood alone as a diagnostic aid to the physician.
It is most appropriate to regard the history of CSF as commencing with descriptive accounts of the meninges and the ventricles; these are the anatomical constraints of the space in which the fluid flows ( fig 1) .
The earliest of these accounts can be traced back to one of the Hippocratic writers (430-350 BC) who made reference to the falx cerebri. This was followed by descriptions of the meninges and ventricles-the lateral, third, and fourth-by the then two best known physicians of the city of Alexandria, namely Erasistratus (c 260 BC) and Herophilus (c 300 BC), but Rufus of Ephesus (AD c 98-117) also contributed some knowledge. Subsequently, Claudius Galen of Pergamum (AD 129-99) gave the first detailed account of the ventricular system; his work, however, was based on ox brain dissections. Nevertheless, there was to be a long wait until 1543 before a more accurate description of the system was provided by Andreas Vesalius (1514-64). Admittedly, Leonardo da Vinci (1452-1519) had produced a wax cast of the human ventricular system in about 1504, but his work was unknown and it had therefore been without influence until the 19th century. Vesalius's account of the ventricular system was extended and improved upon by Giulio Aranzi (1530-89) in 1587; he provided a clearer description of the temporal horns of the lateral ventricles and of the choroid plexus. Moreover, he was the first to refer to the passage leading from the third to the fourth ventricle as an "aqueduct"; this passage was later named after Fransois de It was in the second century that Claudius Galen found there to be a clear fluid residue in the ventricles of the living brain. His work had been based on animal studies and he described the fluid as a vaporous humour produced by the brain-which he surmised provided energy for the whole body. This historical account comprised the first recognition of CSF. Moreover, this description of the fluid was an extension of the earlier concept of "vitalism", on which hinged the basic beliefs of Greek medicine of the time as to how the human body functioned. According to their views the heart produced a vital spirit which was the vaporous life determinant (referred to as psychic "pneuma") and which was distributed peripherally to every organ in the body. 2 The The formal examination of CSF started with development and perfection of the technique of lumbar puncture in 1891 by Heinrich Quinke (1842-1922)9; this was achieved while he was searching for a safe and simple way to remove the excess fluid in children with hydrocephalus. Quinke is credited as being the first to examine in detail the constituents of CSF. He counted the cells, measured total protein by the Kjeldahl method and identified the presence of bacteria in the fluid in pathological circumstances. However, it took another 20 years before the first comprehensive description of the chemical composition of CSF was made in 1911 by William Mestrezat (1883 -1928 .1o The earliest report of the diagnostic value of analysing CSF biochemically was made in 1893 by Ludwig Lichtheim (1845-1928) when he observed that glucose levels were low in both bacterial and tuberculous meningitis."l Since that time glucose has been routinely measured in CSF.
The bacteriological diagnosis of meningitis was made possible at this time because of progress that had been made previously in the field of microbiology. Such advances included the description of a technique for the staining of bacteria in 1875 by Carl Weigert . This was succeeded by a method for cultivating bacteria in 1877, followed by a modification of it in 1881 in order to obtain pure cultures, both techniques having been developed by Robert Koch (1843-19 10). Subsequently, Christian Hans Gram (b. 1853) published his now famous method for the differential staining of bacteria, the "Gram stain", in 1884. In the following year, the Ziehl-Neelsen stain for identifying the tubercle bacillus was described; it was based on the work of Franz Ziehl (1857-1926) and Freidrich Neelsen (1854-94).' All these procedures were also applied to CSF. That the CSF occasionally contained yellow pigment was discovered soon after lumbar puncture had been adopted as a routine clinical procedure. This yellow discoloration was also observed in the supernatant CSF in cases of subarachnoid haemorrhage by Millian and Chiray in 1902 and they proposed the term "xanthochromia" to describe the phenomenon. '6 In the following seven years, cases of xanthochromia, each being in association with a seemingly different aetiopathogenesis, were described. Georges Froin (1874 Froin ( -1903 Kabat (b. 1914) and associates who, on employing the Tiselius free boundary electrophoretic method, found increased concentrations of y globulin in the fluid of both neurosyphilis and multiple sclerosis patients. Moreover, they showed that these changes were independent of those in serum, suggesting that immunoglobulins were produced within the CNS in such diseases. 23 In 1948, Kabat et al, for the first time, used an immunochemical (precipitin) method to quantify albumin and globulin in human CSF without prior concentration of the fluid. They established reference ranges for these analytes and confirmed the increase in y globulin fractions in multiple sclerosis.24 However, a severe limitation of the precipitin method actually used was that it required no less than 6-7 ml of CSF for duplicate albumin and y globulin estimations.
Measurement of CSF sugar and proteins had become established as being an important diagnostic aid by the first quarter of the 20th century. Biochemical developments in this area subsequently concentrated on further refining the analytical techniques and their applications to measuring CSF analytes. Examples included the practice of interpreting CSF sugar concentrations in relation to plasma values, which can be traced back to 1925 when George Goodwin and Harold Shelley established the dependence of the former on the latter. 25 An important development in CSF glucose assay during the course of this century was the advent of the enzymatic glucose-oxidase and hexokinase methods. Hitherto, CSF glucose had been estimated principally by non-specific reducing methods, involving reduction of copper salts. Vincent Marks (b. 1930) studied glucose in CSF, blood, and urine in 1959; he compared lumbar and ventricular CSF glucose using the glucose-oxidase method in 1960.26 In 1973, K A Greenwald and associates used a hexokinase method for quantifying CSF glucose and they re-established the previously described relationship between CSF and serum glucose.27 A new methodology for protein included the turbidimetric estimation of CSF total protein using trichloracetic acid, which had been developed by William Mestrezat (1883 -1928 in 1921.28 F P Kingsbury et al used sulphosalicylic acid instead of trichloracetic acid in a similar turbidimetric procedure in 1926.28 These were the forebears of the methods in common use today. A sensitive colorimetric method for CSF protein was also described by Howe Oliver Lowry in 1952 using the FolinCiocalteu reagent following treatment with an alkaline copper solution. 29 The early 20th century also marked the advent of measurement of lactate in CSF as a potential disease marker. Lactate concentrations were first noted to be increased in the CSF from patients with tuberculous and bacterial meningitis in 1924 by Kikugoro Nishimura.30 However, in marked contrast to glucose, lactate has only recently been occasionally used as an early indicator of bacterial meningitis-as a differential aid in distinguishing this entity from aseptic meningitis.
Another diagnostic test applied to CSF and which was widely used during this period in the assessment of the blood-CSF barrier ("meningeal permeability"), was the "bromide test" described by Friedrich Walter in 1925 and 1929.31 Briefly, the patient takes bromide orally for several days; 24 hours after the last intake, blood and CSF are withdrawn and the ratio of the concentrations ofbromide in plasma to that in CSF is determined; this was called the "permeability quotient". This quotient, which in normal individuals is three, was reported to be reduced in patients with meningitis and multiple sclerosis.32
The second half of the 20th century has witnessed even more rapid development in diagnostic CSF analysis. Quantitative measurements of CSF immunoglobulins were refined, using very precise methods and only requiring minute quantities of fluid; these remained useful in the diagnosis of multiple sclerosis until the early 1970s. 
